Subacromial injection of tranexamic acid improves early postoperative range of motion in arthroscopic rotator cuff repair: a prospective randomized controlled trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20210530002

Enrollment

Registered

2021-05-30

Start date

2021-06-08

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator cuff injury arthroscopic rotator cuff repair, subacromial injection, tranexamic acid

Interventions

A subacromial injection of 15 mg/kg tranexamic acid just prior to incision closure in patients undergoing arthroscopic rotator cuff repair.,A subacromial injection with the same amount of normal salin

Experimental Drug,Placebo Comparator No treatment

Tranexamic acid,Control group

Eligibility

Sex/Gender

All

Age

20 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients diagnosed with a rotator cuff tear.

Exclusion criteria

Exclusion criteria: 1. Allergic to tranexamic acid, 2. Had undergone previous rotator cuff repair, 3. Irreparable rotator cuff tears, 4. Had a history of deep vein thrombosis, 5. Had a history of pulmonary embolism, 6. Had a history of stroke, 7. coronary artery disease

Design outcomes

Primary

Measure	Time frame
Postoperative shoulder range of motion 2, 6, and 12 weeks postoperatively Smartphone clinometers	—

Secondary

Measure	Time frame
Postoperative pain 24 hours postoperatively Visual analog scale	—

Countries

Thailand

Contacts

Public ContactWatcharapon Phoemphunkunarak

Chulalongkorn University

phoemphunkunarak@outlook.co.th66870572002

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026